Cochrane | Trusted evidence. Informed decisions. Better health.
WEBCochrane Iran: A beacon of reliable health information in the Middle East. 2 August 2024. News. Global Evidence Summit 2024: Explore Prague while supporting women in leadership. 1 August 2024. News. Cochrane is a global independent network of researchers, professionals, patients, carers and people interested in health.
Duloxetine for treating painful neuropathy, chronic pain or
WEBThe usual dose of duloxetine is 60 mg. At this dose, there was moderate quality evidence that duloxetine reduced pain in both painful diabetic peripheral neuropathy and fibromyalgia. In diabetic peripheral neuropathic pain, a 50% or better improvement with duloxetine 60 mg per day was just over one and a half times more likely than with placebo.
Bupropion for attention deficit hyperactivity disorder (ADHD
WEBBupropion may be an alternative treatment for adults with ADHD who cannot or will not take stimulant drugs. Quality of the evidence. The quality of the evidence in this review is low, because we found very few studies; five of the six studies were small, and all were poorly conducted. The effect of bupropion on various aspects of daily ...
How accurate are rapid antigen tests for diagnosing COVID-19?
WEBAccurate rapid diagnostic tests for SARS-CoV-2 infection would be a useful tool to help manage the COVID-19 pandemic. Testing strategies that use rapid antigen tests to detect current infection have the potential to increase access to testing, speed detection of infection, and inform clinical and public health management decisions to reduce …
Oral painkillers available without prescription for acute pain
WEBNon-prescription (over-the-counter, or OTC) analgesics (painkillers) are used frequently. They are available in various brands, package sizes, formulations, and dose. They can be used for a range of different types of pain, but this overview reports on how well they work for acute pain (pain of short duration, usually with rapid onset).
What are systematic reviews? - Cochrane
WEBCochrane evidence, including our systematic reviews, provides a powerful tool to enhance your healthcare knowledge and decision making. This video from Cochrane Sweden explains a bit about how we create health evidence and …
Cochrane review of COVID-19 vaccines shows they are effective
WEBDec 7, 2022 · Most trials were no longer than two months in length. The review found that the following vaccines reduced or probably reduced the risk of COVID-19 infection compared to placebo: Pfizer/BioNTech, Moderna, CureVac COVID-19, Oxford-AstraZeneca, Janssen, Sputnik V (Gam-COVID-Vac), Sinopharm (WIBP CorV and …
How accurate are the Addenbrooke's Cognitive Examination III
WEBThere is insufficient information in terms of both quality and quantity to recommend the use of either the ACE-III or mini-ACE for the screening of dementia or MCI in patients presenting with, or at high risk of, cognitive decline.
What are the benefits and risks of occlusal treatment in people …
WEBKey messages. For people with temporomandibular disorders (TMD), using a type of mouth guard known as an occlusal splint may reduce pain in muscles when chewing compared to receiving no treatment, but the results are very uncertain.
What are the benefits and risks of vaccines for preventing COVID …
WEBDec 7, 2022 · Key messages. – Most vaccines reduce, or probably reduce, the number of people who get COVID-19 disease and severe COVID-19 disease. – Many vaccines likely increase number of people experiencing events such as fever or headache compared to placebo (sham vaccine that contains no medicine but looks identical to the vaccine …